XML 80 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8

Note 7 - Customer and Supplier Concentration (Details) - Accounts Receivable and Net Revenues Information for the Company’s Major Customers (Customer Concentration Risk [Member])	9 Months Ended	12 Months Ended	3 Months Ended		9 Months Ended			12 Months Ended	3 Months Ended		9 Months Ended			12 Months Ended	3 Months Ended		9 Months Ended			12 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2014 Actavis, Inc. [Member] Accounts Receivable [Member]	Dec. 31, 2013 Actavis, Inc. [Member] Accounts Receivable [Member]	Sep. 30, 2014 Actavis, Inc. [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 Actavis, Inc. [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 Actavis, Inc. [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 Actavis, Inc. [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 AmerisourceBergen [Member] Accounts Receivable [Member]	Dec. 31, 2013 AmerisourceBergen [Member] Accounts Receivable [Member]	Sep. 30, 2014 AmerisourceBergen [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 AmerisourceBergen [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 AmerisourceBergen [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 AmerisourceBergen [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 Cardinal Health [Member] Accounts Receivable [Member]	Dec. 31, 2013 Cardinal Health [Member] Accounts Receivable [Member]	Sep. 30, 2014 Cardinal Health [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 Cardinal Health [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 Cardinal Health [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 Cardinal Health [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 McKesson [Member] Accounts Receivable [Member]	Dec. 31, 2013 McKesson [Member] Accounts Receivable [Member]	Sep. 30, 2014 McKesson [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 McKesson [Member] Sales Revenue, Net [Member]	Sep. 30, 2014 McKesson [Member] Sales Revenue, Net [Member]	Sep. 30, 2013 McKesson [Member] Sales Revenue, Net [Member]
Revenue, Major Customer [Line Items]
Customer	31.00%	44.00%	35.00%	32.00%	33.00%	34.00%	10.00%	11.00%	14.00%	15.00%	15.00%	15.00%	10.00%	7.00%	13.00%	13.00%	14.00%	14.00%	16.00%	13.00%	19.00%	29.00%	23.00%	26.00%

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611



Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_EntityWideRevenueMajorCustomerLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration